An interventional study of Cognitive Training and Goal Management Training in Delirium, Cognitive Decline and Dementia, sponsored by Vanderbilt University Medical Center. Completed at 2 sites in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-12-24.
Sponsored by Vanderbilt University Medical Center · Not applicable, Interventional, and Treatment
This is a randomized control trial to determine if early cognitive training and rehabilitation improve 4-month cognition in hospitalized older (>=65 years old) delirious patients with and without Alzheimer's disease and related dementias. Enrolled patients will be randomized to receive cognitive intervention versus usual care at a 1:2 allocation ratio. Patients assigned to the cognitive intervention group will receive cognitive training daily during hospitalization and cognitive rehabilitation weekly for 12 weeks after hospital discharge. Patients will be evaluated for global cognition (primary outcome) and secondary outcomes at 4-months.
1,057 studies on the registry are indexed under Delirium; 238 are open to participants now.
This study's enrollment of 283 is above the median of 120 across 599 interventional studies indexed under Delirium.
Browse Delirium studies →Vanderbilt University Medical Center is the lead sponsor of 824 studies on the registry; 164 are open to participants now.
Of its 122 completed or terminated interventional studies of FDA-regulated products, 91 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
During hospitalization, enrolled patients assigned to the intervention arm will undergo two 20-minute cognitive training sessions daily, 7 days a week. After the patient is discharged from the hospital, cognitive rehabilitation will be administered once a week for 12-weeks at their place of residence. Goal Management Training will be the foundation for cognitive rehabilitation.
Behavioral: Cognitive Training · Behavioral: Goal Management Training
Enrolled patients will undergo usual care during hospitalization and post-hospital discharge.
The cognitive training program regimen and its degree of difficulty will be tailored to the patient's current level of cognitive functioning and interests. Patients will be asked to work through progressively more challenging exercises pertaining to orientation, attention, problem-solving, and memory. These cognitive training exercises will be significantly difficult but when they can be completed easily (\>85% mastery), their difficulty will be increased, and this process will be repeated as appropriate. They will also perform puzzles, games, or cognitive tasks related to their hobbies.
Goal management training will (1) teach patients compensatory strategies such as "stop" techniques \[e.g., to "stop and think" about consequences of a decision before making it\]; (2) help them to take complex tasks and divide them into manageable subtasks to increase the likelihood of completing the task; and (3) enable them to learn to regain cognitive control when their behavior becomes incompatible with their intended goals. GMT is anchored in "sustained and vigilant attention theory" and it enables patients to actively attend to "higher order" goals critical to functioning. GMT is tailored to the individual needs of the patient. During the initial session, the Cognitive Intervention Specialist will meet with the subject and their family member or caregiver to identify these functional and cognitive deficiencies.
Global Cognition as Measured by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
A neuropsychological battery for global cognition which evaluates immediate and delayed memory, attention, visuospatial construction, and language. Scores range from 40 to 160, with higher scores indicating better cognition.
Time frame: 4-months
Executive Function as Measured by the Components of the Delis-Kaplan Executive Function System (D-KEFS) Subscales
The D-KEF's Proverbs, Color Word Interference, and Verbal Fluency Category Switching subscales will measure conceptual flexibility, inhibition, and monitoring, respecitvely, which encompasses the majority of executive function. The average of the three subscales will provide an executive function composite score. Scores range from 1 to 18 with higher values indicating better executive function
Time frame: 4-months
Functional Status as Measured by Older American Resources and Services Activities of Daily Living Scale
Characterizes seven basic and seven instrumental activities of daily living. Scores range from 0 to 28 with higher scores indicating better functional status.
Time frame: 4-months
Quality of Life as Measured by the EQ-5D-5L
Characterizes quality of life and contains 5-dimensions ("5D") related to everyday living: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. It asks patients to rate their current global health status from 0 (worst health you can imagine) to 100 (best health you can imagine). Scores range from -0.573 to 1.000 with higher scores indicating better quality of life.
Time frame: 4-months
Vital Status (Dead / Alive)
Death within 4-months will be recorded
Time frame: 4-months
Nursing Home Placement (Yes / no)
Nursing home placement within 4-months will be recorded
Time frame: 4-months
Change in Montreal Cognitive Assessment
Change in global cognition at 4-months compared to enrollment. The Montreal Cognitive Assessment assesses visuospatial, language, naming, memory, attention, abstraction, and orientation, and ranges from 0 to 30 (perfect cognition). It was collected at enrollment, during the delirium episode, and at 4 months.
Time frame: 4-months
| Milestone | Cognitive Intervention | Usual Care |
|---|---|---|
| Started | 97 | 186 |
| Completed | 50 | 102 |
| Not completed | 47 | 84 |
| Withdrew: Death | 31 | 43 |
| Withdrew: Lost to follow-up | 2 | 11 |
| Withdrew: Patient declined to participate | 13 | 26 |
| Withdrew: Patient was physically incapable | 1 | 3 |
| Withdrew: Patient's spouse was had prolongued icu stay | 0 | 1 |
A neuropsychological battery for global cognition which evaluates immediate and delayed memory, attention, visuospatial construction, and language. Scores range from 40 to 160, with higher scores indicating better cognition.
| score on a scale | Cognitive Intervention | Usual Care |
|---|---|---|
| Global Cognition as Measured by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) | 67 (49 to 80) | 67 (52 to 83) |
The D-KEF's Proverbs, Color Word Interference, and Verbal Fluency Category Switching subscales will measure conceptual flexibility, inhibition, and monitoring, respecitvely, which encompasses the majority of executive function. The average of the three subscales will provide an executive function composite score. Scores range from 1 to 18 with higher values indicating better executive function
| score on a scale | Cognitive Intervention | Usual Care |
|---|---|---|
| Executive Function as Measured by the Components of the Delis-Kaplan Executive Function System (D-KEFS) Subscales | 5.5 (3 to 8) | 4.0 (0 to 11) |
Characterizes seven basic and seven instrumental activities of daily living. Scores range from 0 to 28 with higher scores indicating better functional status.
| score on a scale | Cognitive Intervention | Usual Care |
|---|---|---|
| Functional Status as Measured by Older American Resources and Services Activities of Daily Living Scale | 9 (2 to 16) | 8 (3 to 13) |
Characterizes quality of life and contains 5-dimensions ("5D") related to everyday living: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. It asks patients to rate their current global health status from 0 (worst health you can imagine) to 100 (best health you can imagine). Scores range from -0.573 to 1.000 with higher scores indicating better quality of life.
| score on a scale | Cognitive Intervention | Usual Care |
|---|---|---|
| Quality of Life as Measured by the EQ-5D-5L | 0.352 (0.096 to 0.727) | 0.269 (0.096 to 0.465) |
Death within 4-months will be recorded
| Participants | Cognitive Intervention | Usual Care |
|---|---|---|
| Vital Status (Dead / Alive) | 31 | 43 |
Nursing home placement within 4-months will be recorded
| Participants | Cognitive Intervention | Usual Care |
|---|---|---|
| Nursing Home Placement (Yes / no) | 2 | 2 |
Change in global cognition at 4-months compared to enrollment. The Montreal Cognitive Assessment assesses visuospatial, language, naming, memory, attention, abstraction, and orientation, and ranges from 0 to 30 (perfect cognition). It was collected at enrollment, during the delirium episode, and at 4 months.
| score on a scale | Cognitive Intervention | Usual Care |
|---|---|---|
| Change in Montreal Cognitive Assessment | 3.5 (0 to 6.5) | 4 (0 to 11) |
Collected over From enrollment to the 4-month follow-up. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Cognitive Intervention | 31/97 (32%) | 0/97 (0%) | 0/97 (0%) |
| Usual Care | 43/186 (23.1%) | 0/186 (0%) | 0/186 (0%) |
| Age, Categorical(Participants) | Cognitive Intervention | Usual Care | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 0 | 0 | 0 |
| >=65 years | 97 | 186 | 283 |
| Age, Continuous(years) | Cognitive Intervention | Usual Care | Total |
|---|---|---|---|
| Median | 76 (71 to 82) | 75 (70.3 to 82.0) | 75 (71 to 82) |
| Sex: Female, Male(Participants) | Cognitive Intervention | Usual Care | Total |
|---|---|---|---|
| Female | 42 | 89 | 131 |
| Male | 55 | 97 | 152 |
| Race (NIH/OMB)(Participants) | Cognitive Intervention | Usual Care | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 1 | 1 | 2 |
| Native Hawaiian or Other Pacific Islander | 0 | 1 | 1 |
| Black or African American | 14 | 27 | 41 |
| White | 81 | 154 | 235 |
| More than one race | 1 | 2 | 3 |
| Unknown or Not Reported | 0 | 1 | 1 |
Documents are hosted by the registry — open the source record to download them.
Plan to share: Yes
Supporting information: Study protocol, Sap, Icf, Analytic code
This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Vanderbilt University Medical Center